Julian M. Mackay-Wiggan, MD, MS

Expertise in: 
Hair Disorders, General Dermatology, Cosmetic Dermatology
Board Certifications: 
Dermatology
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Hair Disorders, General Dermatology, Cosmetic Dermatology, Dermatitis, Eczema

Academic Appointments

  • Associate Professor of Dermatology at CUMC

Administrative Titles

  • Director, Dermatology Clinical Research Unit
  • Director, Dermatology Resident (ACN) Clinic

Julian M. Mackay-Wiggan, MD, MS - Dermatologist at ColumbiaDoctors

Dr. Mackay Wiggan is an Associate Professor of Dermatology at CUMC. She sees patients in private practice at the Herbert Irving Pavilion. Her primary clinical interest is in the evaluation and treatment of all varieties of hair loss, but she also sees patients for all general dermatologic concerns including skin cancer examinations, acne, rashes, and cosmetic procedures.

Dr. Mackay-Wiggan enjoys teaching the next generation of dermatologists and she accomplishes this as Director of the Ambulatory Care Network Dermatology clinic. She actively supervises and teaches residents in the Dermatology Adult ambulatory care clinic (resident practice). 

Dr. Mackay-Wiggan is dedicated to furthering the specialty of Dermatology through research endeavors and is the Director of the Clinical Research Unit in the Department of Dermatology at Columbia University. She completed a Master of Science in Biostatistics/Patient Oriented Research at the Columbia University School of Public Health, and has extensive experience in designing and conducting clinical research projects of varying complexity and design for treatment of many dermatologic conditions, including hair loss. She also supervises and trains the clinical research fellow.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Spanish

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-5293

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Dermatology

Honors & Awards

May 1993- Graduated Magna Cum Laude with Honors in Psychology, Brooklyn College, City University of New York

May 1993 - Elected to Phi Beta Kappa National Honor Society and Golden Key National Honor Society – Brooklyn College, City University of New York

July to August 1995 - Dean’s Summer Research Fellowship- Columbia University,    College of Physicians and Surgeons

January 2001 - 2nd place Dermatologic Society of Greater NY Residents Competition

May 2001 - 1st place Annual Residents Competition – Department of Dermatology, Columbia University, 2001

June 2001 to December 2001 Chief Resident - Department of Dermatology, Columbia University, College of Physicians and Surgeons

January 2002 - 1st place Dermatologic Society of Greater NY Residents Competition

August 2002- May 2004   Master of Science training funding supported by receipt of a competitive Clinical Research Training Grant funded through the NIH/Columbia University CTSA – Irving Institute.

Research

Research Interests

  • Dermatology clinical trials

Grants

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL DOSESTUDY TO EVALUATE THE SAFETY AND EFFICACY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA (P&S Industry Clinical Trial)

Jan 24 2017 - Jan 24 2022

ALOPECIA AREATA CENTER FOR RESEARCH TRANSLATION (AACORT) (Federal Gov)

Sep 1 2016 - Aug 31 2021

COLUMBIA UNIVERSITY SKIN DISEASE RESOURCE-BASED CENTER (EPICURE) (Federal Gov)

Aug 1 2016 - Jul 31 2021

DEVELOPING AN ALOPECIA AREATA DISEASE ACTIVITY INDEX (ALADIN) (Federal Gov)

Sep 1 2014 - Aug 31 2018

A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INDUCTION AND MAINTENANCE REGIMENS OF BRODALUMAB COMPARED WITH PLACEBO AND USTEKINUMAB IN SUBJECTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: AMAGINE-3 (P&S Industry Clinical Trial)

Jun 5 2013 - Jun 5 2018

A PHASE 2, MULTI-CENTER, RANDOMIZED,DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF R333 6% OINTMENT ADMINISTERED TOPICALLY TO DLE AND DLE PATIENTS WITH ACTIVE CUSTANEOUS DISCOID LESIONS (P&S Industry Clinical Trial)

Mar 8 2013 - Mar 8 2018

A PROSPECTIVE OBSERVATIONAL STUDY OF TREATMENT PATTERNS AND EFFECTIVENESS AND SAFETY OUTCOMES IN ADVANCED BASAL CELL CARCINOMA (P&S Industry Clinical Trial)

Jan 30 2013 - Jan 30 2018

OBSERVATIONAL POST-MARKETING SAFETY SURVEILLANCE REGISTRY OF ENBREL (ETANERCEPT) FOR TREATMENT OF PSORIASIS (P&S Industry Clinical Trial)

Jul 20 2006 - Feb 28 2016

A RANDOMIZED,DOUBLE-BLIND,12 WEEK,DOSE-RANGING,PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL VB20 (P&S Industry Clinical Trial)

Apr 3 2001 - Apr 30 2015

AN OPEN LABEL TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF AMPREMILAST IN THE TREATMENT OF ROSACEA IN PATIENTS WITH BOT (P&S Industry Clinical Trial)

Feb 10 2010 - Feb 10 2015

RESTASIS OPHTHALMIC EMULSION FOR THE TREATMENT OF BRITTLE NAILS (P&S Industry Clinical Trial)

Aug 17 2009 - Aug 17 2014

ABBOTT LAB -- M10016 (P&S Industry Clinical Trial)

Jul 8 2008 - Dec 31 2011

ABBOTT -- M06-890 (P&S Industry Clinical Trial)

Feb 29 2008 - Aug 31 2009